insights_auto
Outlook: 30.8% bullish·10.3% bearish
Go to analysischevron_right
PFE:NYSE
Pfizer Inc
$27.71
arrow_downward
-1.28%(-0.36) 1D
Nov 19, 11:56:01 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFE...
Open
$27.92
High
$27.99
Low
$27.44
Mkt. cap
158.00B
Avg. vol.
34.38M
Volume
14.60M
Dividend
6.20%
Quarterly dividend
$0.43
Ex-dividend date
Nov 6, 2026
P/E ratio
39.64
52-wk high
$31.44
52-wk low
$23.62
EPS
$0.70
Beta
0.31
Shares outstanding
5.70B
No. of employees
75K
Open
$27.92
High
$27.99
Low
$27.44
Mkt. cap
158.00B
Avg. vol.
34.38M
Volume
14.60M
Dividend
6.20%
Quarterly dividend
$0.43
Ex-dividend date
Nov 6, 2026
P/E ratio
39.64
52-wk high
$31.44
52-wk low
$23.62
EPS
$0.70
Beta
0.31
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
The Globe and Mail
·
30 minutes ago
Can New Products and Acquisitions Revive Pfizer's Growth Story?
Zacks
·
1 hour ago
Can New Products and Acquisitions Revive Pfizer's Growth Story?
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
Sector-
Industry-
Websitepfizer.com